Status:
UNKNOWN
Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary Hypertension
Lead Sponsor:
Louisiana State University Health Sciences Center in New Orleans
Collaborating Sponsors:
Scleroderma Foundation
Tulane University Health Sciences Center
Conditions:
Scleroderma
Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Systemic sclerosis (SSc, AKA scleroderma) is an autoimmune condition characterized by endothelial damage and progressive fibrosis of the skin and internal organs. One of the leading causes of morbidit...
Eligibility Criteria
Inclusion
- 1\. Age \>18 years 2. Meet American College of Rheumatology criteria for SSc
Exclusion
- Chronic kidney disease (estimated creatinine clearance \<50mL/min)
- Uncontrolled hypertension (diastolic blood pressure\>120mmHg)
- Acute coronary syndrome within the past 6 months
- Chronic obstructive pulmonary disease
- Diabetes mellitus
- Hemolytic anemia
- Active tobacco abuse
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03459716
Start Date
June 1 2018
End Date
December 1 2021
Last Update
September 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center-New Orleans
New Orleans, Louisiana, United States, 70112